The study demonstrates a direct predictive relationship between the important metabolic biomarkers (insulin, glucose), and subclinical atherosclerosis, the basic pathological mechanism underlying hypertension and clinical CVD. The results give an explanation to the increased risk of CVD associated with insulin resistance and hyperglycemia. This evidence concerns the gene INS and Insulin resistance.